免疫調節と表面受容を統合した二重機能の抗血栓性ヒドロゲルコーティング,炎症条件下における血管インプラントの表面受容
Yage Hu1, Yao Xiong1, Tiantian Zheng1
1National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Sichuan University, Chengdu, 610064, China.
Acta biomaterialia
|February 15, 2026
まとめ
この研究は,表面受動化と免疫調節を組み合わせて,血栓形成を減らす心臓血管器具のための新しいヒドロゲルコーティングを開発しました. コーティングは,高リスク患者の凝結と炎症を効果的に予防します.
科学分野:
- バイオマテリアル科学 バイオマテリアル科学
- 免疫学 免疫学とは
- 心血管工学は,心臓血管工学である.
背景:
- 心血管移植装置は,特に全身性炎症の患者では,しばしば血栓形成を引き起こします.
- 従来の抗血栓性コーティングは,炎症と凝固の間の相互作用に対処できないことによって制限されています.
研究 の 目的:
- 表面パッシベーションと免疫調節機能を備えた,シナギスティックな抗血栓性ヒドロゲルコーティングを開発する.
- 炎症条件下で血栓形成を防止し,免疫応答を調節するコーティングの有効性を評価する.
主な方法:
- ポリウレタン (PU) 基板の上に,2-メタクリロイロキシエチルフォスフォリルコリン (MPC) と4-アミノ-2,2,6,6-テトラメチルピペリジン-1-オキシル (テンポル) を使用したズウィットリオンコーティングの製造.
- タンパク質の吸収,血小板の粘着,フリーラジカルの除去,および細胞互換性のインビトロ評価.
- 中枢静脈カテーテルを使用したリポポリサッカリド (LPS) 誘発性全身性炎症のウサギモデルにおけるin vivo評価.
主要な成果:
- このコーティングは,タンパク質の吸収と血小板の粘着を in vitro で著しく減少させた.
- コーティングは,優れたフリーラジカル除去能力と良好な細胞互換性を示しました.
- In vivoでは,このコーティングにより,血栓形成と,導管の周りの炎症性細胞の浸透が著しく減少しました.
- コーティングは,プロ炎症的なM1から抗炎症的なM2フェノタイプへのマクロファージの偏分を促進しました.
結論:
- シナージスティックなヒドロゲルコーティングは,物質-バイオインターフェースとローカル免疫マイクロ環境を効果的に調節します.
- この二重機能戦略は,炎症性条件下で抗血栓性特性を維持します.
- 開発されたコーティングは,高リスク患者向けの抗血栓性血液接触装置の設計に有望な方向性を提供します.
関連する概念動画
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
Introduction to Hemostasis
14.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
14.3K
Vascular Spasm
4.9K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
4.9K
Formation of the Platelet Plug
6.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.3K
Clot Retraction and Fibrinolysis
6.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.1K


